Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)

Clinical trial NCT07492888 · WITHDRAWN

Trial details

NCT number: NCT07492888
Sponsor: ImmunityBio, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Severe Community-Acquired Pneum Sepsis Lymphopenia / Immunoparalysis in Critically Ill Adults

Start date: 2026-04-15
Primary completion: 2026-11-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.